Ohio to end GLP-1 drug weight loss coverage for state workers COLUMBUS, Ohio (WSYX) The Ohio Department of Administrative Services announced that coverage for GLP-1 drugs for weight loss, including Ozempic and Mounjaro, will end for state employees on July 1, 2025
[DOI] [PMC free article] [PubMed] [Google Scholar] [97].Fineman M, Flanagan S, Taylor K, Aisporna M, Shen LZ, Mace KF, Walsh B, Diamant M, Cirincione B, Kothare P, Li WI, MacConell L, Pharmacokinetics and pharmacodynamics of exenatide extended-release after single and multiple dosing, Clinical pharmacokinetics, 50 (2011) 6574
Yet as these data show, Southern residents are less likely than others to have access to GLP-1 drugs in state regulated health insurance markets, providing another example of how state of residence can affect access to healthcare in critical ways.
Even among insured adults, more than 50 percent of people who take GLP-1s say its difficult to afford the medication, according to a 2024 poll from the Kaiser Family Foundation